Use and treatment of di-amino acid repeat-containing proteins associated with ALS
US12025622B2 · kind B2 · utility
3Cited by
12References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2021 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Feb 6, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/285
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for identifying and/or treating subjects having or likely to have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). Antibodies specific for one or more di-amino acid repeat-containing proteins are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.